Recommended videos
Amarin (AMRN) FDA Acceptance f
15 views
14 éve
Pfizer - FDA Approves XALKORI
49 views
15 éve
(SLB, BIOD, INSM) CRWENewswire
12 views
14 éve
(ARJ, YRCW, SRX) CRWENewswire
37 views
15 éve
Seattle Genetics Inc. (SGEN)
25 views
15 éve
(SZYM, PKT, OPXA) CRWENewswire
11 views
Opexa Therapeutics Incorporated - symbol OPXA - reported that its lead drug candidate Tovaxin has been granted Fast Track designation by the FDA for the treatment of patients with Secondary Progressive Multiple Sclerosis
Date:
2011. 11. 08.
Tags:
Add to list
Recommended videos
(MYL, NYT, NSPH) CRWENewswire
12 views
14 éve
(FTK, DVOX, ARWR) CRWENewswire
16 views
14 éve
(KNXA, BBND, JNY) CRWENewswire
19 views
15 éve
SDIX -CRWENewswire Stock Watch
22 views
14 éve
(EK, ENMD, EBS) CRWENewswire
69 views
15 éve
MELA, FCEL, QPSA) CRWENewswire
16 views
15 éve
(TPC, CRWE, TEVA) CRWENewswire
34 views
14 éve
GMCR, STEM, DSCO) CRWENewswire
19 views
14 éve
(RMBS, CMG, HII) CRWENewswire
81 views
14 éve
INTL FCStone (INTL)
8 views
15 éve
(LNCR, AGX, JMBA) CRWENewswire
16 views
14 éve
MYGN, FIRE, FURX) CRWENewswire
14 views
14 éve
Ventrus Biosciences (VTUS)
18 views
14 éve

(MYL, NYT, NSPH) CRWENewswire
12 views
14 éve
(FTK, DVOX, ARWR) CRWENewswire
16 views
14 éve
(KNXA, BBND, JNY) CRWENewswire
19 views
15 éve
SDIX -CRWENewswire Stock Watch
22 views
14 éve
(EK, ENMD, EBS) CRWENewswire
69 views
15 éve
MELA, FCEL, QPSA) CRWENewswire
16 views
15 éve
(TPC, CRWE, TEVA) CRWENewswire
34 views
14 éve
GMCR, STEM, DSCO) CRWENewswire
19 views
14 éve
(RMBS, CMG, HII) CRWENewswire
81 views
14 éve
INTL FCStone (INTL)
8 views
15 éve
(LNCR, AGX, JMBA) CRWENewswire
16 views
14 éve
MYGN, FIRE, FURX) CRWENewswire
14 views
14 éve
Ventrus Biosciences (VTUS)
18 views
14 éve
Facebook
X / Twitter
Tumblr
Reddit
Telegram
WhatsApp
LinkedIn
E-mail